ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NITE Nightstar Therapeutics Plc ADS

25.41
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nightstar Therapeutics Plc ADS NASDAQ:NITE NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 25.41 18.50 25.41 0 01:00:00

Knight Libertas UK Appoints Ron Thompson as Managing Director, Global Head of ABS Strategy

05/01/2010 8:30am

PR Newswire (US)


Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart


From Oct 2019 to Oct 2024

Click Here for more Nightstar Therapeutics Plc ADS Charts.
JERSEY CITY, N.J. and LONDON, Jan. 5 /PRNewswire-FirstCall/ -- Knight Capital Group, Inc. (NASDAQ:NITE) today announced that Knight Libertas UK appointed Ronald E. Thompson, Jr. as Managing Director, Global Head of ABS Strategy, effective as of November 30, 2009. "Ron brings considerable experience to our securitized products effort in the U.S. and Europe and broadens the services we provide to our institutional structured securities clients," said Ronak Khichadia, Managing Director, Global Head of ABS/MBS sales and trading. "We intend to further leverage our intellectual capital to enhance the products and services we deliver to clients as Ron helps us build out our ABS/MBS strategy and analytics platform to support sales and trading. We are growing our platform globally to meet the opportunities, and strategy will play a key role in helping us expand our franchise across the structured markets." Knight Libertas is an institutional fixed income broker-dealer providing trade execution, fundamental investment research across a broad range of fixed income securities including ABS/MBS. Knight Libertas also provides secondary market liquidity and credit-based analysis for High Grade and High Yield Bonds, Bank Loans, Emerging Market Credit and Sovereigns as well as and capital markets services for corporate issuers. "I am pleased to join Knight Libertas and look forward to working with the team to build a strong ABS/MBS platform. Knight Libertas already boasts extensive research and strategy capabilities in other fixed income arenas, namely High Yield and Emerging Markets. The ABS/MBS sales and trading groups in the U.S. and Europe have quickly established themselves as core trading counterparties, and they intend to add to that strength with a build out in analytics and strategy," said Thompson. Mr. Thompson is based in the London office, phone +44 (0)20 7997 2163 or email . Knight Libertas UK is a division of Knight Capital Europe Limited, which is a wholly-owned subsidiary of Knight Capital Group, Inc. Biography Ronald E. Thompson, Jr. Managing Director, Global Head of ABS Strategy Knight Libertas UK Ronald. E. Thompson is Managing Director, Global Head of ABS Strategy. Mr. Thompson joined Knight Libertas from the Royal Bank of Scotland where he spent eight years, most recently as global head of ABS strategy in Stamford and London. Before RBS, Thompson held research and strategy roles with Citigroup and Salomon Brothers as well as banking and research roles in several other institutions. Highly ranked in Euromoney and Institutional Investor polls, Ron's research on ABS and CDOs has also appeared in several books, including the "Handbook of Bank Loans", "Handbook of Structured Financial Products", "Guide to Mortgage and Asset Backed Securities", and "Reserve Management Trends". Ron has a bachelor of science in engineering with distinction from Worcester Polytechnic Institute. About Knight Knight Capital Group, Inc. (NASDAQ:NITE) is a global capital markets firm that provides market access and trade execution services across multiple asset classes to buy- and sell-side firms. Knight's hybrid market model features complementary electronic and voice trade execution services in global equities and fixed income as well as foreign exchange, futures and options. The firm is consistently ranked as the leading source of off-exchange liquidity in U.S. equities. Knight also provides capital markets services to corporate issuers. Knight is headquartered in Jersey City, NJ with a growing global presence across North America, Europe and the Asia-Pacific region. For more information, please go to http://www.knight.com/. Certain statements contained herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict including, without limitation, risks associated with the costs, integration, performance and operation of businesses recently acquired, or that may be acquired in the future, by the Company and risks related to the costs and expenses associated with the Company's exit from the Asset Management business. Since such statements involve risks and uncertainties, the actual results and performance of the Company may turn out to be materially different from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made herein. Readers should carefully review the risks and uncertainties disclosed in the Company's reports with the U.S. Securities and Exchange Commission (SEC), including, without limitation, those detailed under the headings "Certain Factors Affecting Results of Operations" and "Risk Factors" in the Company's Annual Report on Form 10-K for the year-ended December 31, 2008, and in other reports or documents the Company files with, or furnishes to, the SEC from time to time. This information should also be read in conjunction with the Company's Consolidated Financial Statements and the Notes thereto contained in the Company's Annual Report on Form 10-K for the year-ended December 31, 2008, and in other reports or documents the Company files with, or furnishes to, the SEC from time to time. DATASOURCE: Knight Capital Group, Inc. CONTACT: Margaret Wyrwas, Senior Managing Director, Communications, Marketing & Investor Relations, Knight Capital Group, Inc., +1-201-557-6954, , Kara Fitzsimmons, Director, Media Relations, Knight Capital Group, Inc., +1-201-356-1523, , Jonathan Mairs, Vice President, Corporate Communications, Knight Capital Group, Inc., +1-201-356-1529, , or Jennifer Day, Vice President, Marketing Communications - Institutional Fixed Income, +1-201-356-1506, Web Site: http://www.knight.com/

Copyright

1 Year Nightstar Therapeutics Plc ADS Chart

1 Year Nightstar Therapeutics Plc ADS Chart

1 Month Nightstar Therapeutics Plc ADS Chart

1 Month Nightstar Therapeutics Plc ADS Chart

Your Recent History

Delayed Upgrade Clock